Signalling processes involved in C-peptide-induced chemotaxis of CD4-positive lymphocytes

Cellular and Molecular Life Sciences

Volumn 66, Issue 11-12, 2009, Pages 1974-1984

  Aleksic, M ^a   Walcher, D ^a   Giehl, K ^a   Bach, H ^a   Grub M ^a   Durst, R ^a   Hombach, V ^a   Marx, N ^a  

^a UNIVERSITY OF ULM   (Germany)

Author keywords

Atherosclerosis; C peptide; CD4 positive lymphocytes; Migration; Signalling

Indexed keywords

C PEPTIDE;

ARTICLE; CD4+ T LYMPHOCYTE; CELL CULTURE; DRUG EFFECT; ENZYME ACTIVATION; HUMAN; METABOLISM; MICROFILAMENT; NEUTROPHIL CHEMOTAXIS; PHOSPHORYLATION; PHYSIOLOGY; SIGNAL TRANSDUCTION;

C-PEPTIDE; CD4-POSITIVE T-LYMPHOCYTES; CELLS, CULTURED; CHEMOTAXIS, LEUKOCYTE; ENZYME ACTIVATION; HUMANS; MICROFILAMENTS; PHOSPHORYLATION; SIGNAL TRANSDUCTION;

EID: 70349306994     PISSN: 1420682X     EISSN: 14209071     Source Type: Journal    
DOI: 10.1007/s00018-009-9057-y     Document Type: Article

References (59)

1. Tager, H. S., Emdin, S. O., Clark, J. L. and Steiner, D. F. (1973). Studies on the conversion of proinsulin to insulin. II. Evidence for a chymotrypsin-like cleavage in the connecting peptide region of insulin precursors in the rat. J. Biol. Chem. 248, 3476-82.
2. Brandenburg, D. (2008). History and diagnostic significance of C-peptide. Exp. Diabetes Res. 2008, 576862.
3. Wahren, J., Ekberg, K. and Jornvall, H. (2007). C-peptide is a bioactive peptide. Diabetologia 50, 503-9.
4. Walcher, D., Aleksic, M., Jerg, V., Hombach, V., Zieske, A., Homma, S., Strong, J. and Marx, N. (2004). C-peptide induces chemotaxis of human CD4-positive cells: involvement of pertussis toxin-sensitive G-proteins and phosphoinositide 3-kinase. Diabetes 53, 1664-70.
5. Marx, N., Walcher, D., Raichle, C., Aleksic, M., Bach, H., Grub, M., Hombach, V., Libby, P., Zieske, A., Homma, S. and Strong, J. (2004). C-peptide colocalizes with macrophages in early arteriosclerotic lesions of diabetic subjects and induces monocyte chemotaxis in vitro. Arterioscler. Thromb. Vasc. Biol. 24, 540-5.
6. Walcher, D., Babiak, C., Poletek, P., Rosenkranz, S., Bach, H., Betz, S., Durst, R., Grub, M., Hombach, V., Strong, J. and Marx, N. (2006). C-Peptide induces vascular smooth muscle cell proliferation: involvement of SRC-kinase, phosphatidylinositol 3-kinase, and extracellular signal-regulated kinase 1/2. Circ. Res. 99, 1181-7.
7. Kukhtina, N. B., Arefieva, T. I. and Krasnikova, T. L. (2005). Intracellular signal cascade in CD4+ T-lymphocyte migration stimulated by interferon-gamma-inducible protein-10. Biochemistry (Mosc) 70, 652-6.
8. Zheng, Y. and Quilliam, L. A. (2003). Activation of the Ras superfamily of small GTPases. Workshop on exchange factors. EMBO Rep. 4, 463-8.
9. Heasman, S. J. and Ridley, A. J. (2008). Mammalian Rho GTPases: new insights into their functions from in vivo studies. Nat. Rev. Mol. Cell Biol. 9, 690-701.
10. Burridge, K. and Wennerberg, K. (2004). Rho and Rac take center stage. Cell 116, 167-79.
11. Ridley, A. J. (2001). Rho GTPases and cell migration. J. Cell Sci. 114, 2713-22.
12. Raftopoulou, M. and Hall, A. (2004). Cell migration: Rho GTPases lead the way. Dev. Biol. 265, 23-32.
13. Sanchez-Madrid, F. and del Pozo, M. A. (1999). Leukocyte polarization in cell migration and immune interactions. Embo J. 18, 501-11.
14. Takai, Y., Sasaki, T. and Matozaki, T. (2001). Small GTP-binding proteins. Physiol. Rev. 81, 153-208.
15. Riento, K. and Ridley, A. J. (2003). Rocks: multifunctional kinases in cell behaviour. Nat. Rev. Mol. Cell Biol. 4, 446-56.
16. Bokoch, G. M. (2003). Biology of the p21-activated kinases. Annu. Rev. Biochem. 72, 743-81.
17. Chong, C., Tan, L., Lim, L. and Manser, E. (2001). The mechanism of PAK activation. Autophosphorylation events in both regulatory and kinase domains control activity. J. Biol. Chem. 276, 17347-53.
18. Arber, S., Barbayannis, F. A., Hanser, H., Schneider, C., Stanyon, C. A., Bernard, O. and Caroni, P. (1998). Regulation of actin dynamics through phosphorylation of cofilin by LIM-kinase. Nature 393, 805-9.
19. Edwards, D. C., Sanders, L. C., Bokoch, G. M. and Gill, G. N. (1999). Activation of LIM-kinase by Pak1 couples Rac/Cdc42 GTPase signalling to actin cytoskeletal dynamics. Nat. Cell Biol. 1, 253-9.
20. Arai, A., Jin, A., Yan, W., Mizuchi, D., Yamamoto, K., Nanki, T. and Miura, O. (2005). SDF-1 synergistically enhances IL-3-induced activation of the Raf-1/MEK/Erk signaling pathway through activation of Rac and its effector Pak kinases to promote hematopoiesis and chemotaxis. Cell. Signal. 17, 497-506.
21. Cantrell, D. (2002). Protein kinase B (Akt) regulation and function in T lymphocytes. Semin. Immunol. 14, 19-26.
22. Zhang, S., Han, J., Sells, M. A., Chernoff, J., Knaus, U. G., Ulevitch, R. J. and Bokoch, G. M. (1995). Rho family GTPases regulate p38 mitogen-activated protein kinase through the downstream mediator Pak1. J. Biol. Chem. 270, 23934-6.
23. Rousseau, S., Houle, F., Landry, J. and Huot, J. (1997). p38 MAP kinase activation by vascular endothelial growth factor mediates actin reorganization and cell migration in human endothelial cells. Oncogene 15, 2169-77.
24. Vlahakis, S. R., Villasis-Keever, A., Gomez, T., Vanegas, M., Vlahakis, N. and Paya, C. V. (2002). G protein-coupled chemokine receptors induce both survival and apoptotic signaling pathways. J. Immunol. 169, 5546-54.
25. Wilflingseder, D., Mullauer, B., Schramek, H., Banki, Z., Pruenster, M., Dierich, M. P. and Stoiber, H. (2004). HIV-1-induced migration of monocyte-derived dendritic cells is associated with differential activation of MAPK pathways. J. Immunol. 173, 7497-505.
26. Fujita, T., Azuma, Y., Fukuyama, R., Hattori, Y., Yoshida, C., Koida, M., Ogita, K. and Komori, T. (2004). Runx2 induces osteoblast and chondrocyte differentiation and enhances their migration by coupling with PI3K-Akt signaling. J. Cell Biol. 166, 85-95.
27. Steinle, J. J., Meininger, C. J., Forough, R., Wu, G., Wu, M. H. and Granger, H. J. (2002). Eph B4 receptor signaling mediates endothelial cell migration and proliferation via the phosphatidylinositol 3-kinase pathway. J. Biol. Chem. 277, 43830-5.
28. Marx, N., Kehrle, B., Kohlhammer, K., Grub, M., Koenig, W., Hombach, V., Libby, P. and Plutzky, J. (2002). PPAR activators as antiinflammatory mediators in human T lymphocytes: implications for atherosclerosis and transplantation-associated arteriosclerosis. Circ. Res. 90, 703-10.
29. Stahle, M., Veit, C., Bachfischer, U., Schierling, K., Skripczynski, B., Hall, A., Gierschik, P. and Giehl, K. (2003). Mechanisms in LPA-induced tumor cell migration: critical role of phosphorylated ERK. J. Cell Sci. 116, 3835-46.
30. Amano, M., Ito, M., Kimura, K., Fukata, Y., Chihara, K., Nakano, T., Matsuura, Y. and Kaibuchi, K. (1996). Phosphorylation and activation of myosin by Rho-associated kinase (Rho-kinase). J. Biol. Chem. 271, 20246-9.
31. Bamburg, J. R. (1999). Proteins of the ADF/cofilin family: essential regulators of actin dynamics. Annu. Rev. Cell Dev. Biol. 15, 185-230.
32. Hills, C. E. and Brunskill, N. J. (2008). Intracellular signalling by C-peptide. Exp. Diabetes Res. 2008, 635158.
33. Rigler, R., Pramanik, A., Jonasson, P., Kratz, G., Jansson, O. T., Nygren, P., Stahl, S., Ekberg, K., Johansson, B., Uhlen, S., Uhlen, M., Jornvall, H. and Wahren, J. (1999). Specific binding of proinsulin C-peptide to human cell membranes. Proc. Natl. Acad. Sci. U S A 96, 13318-23.
34. Zhong, Z., Davidescu, A., Ehren, I., Ekberg, K., Jornvall, H., Wahren, J. and Chibalin, A. V. (2005). C-peptide stimulates ERK1/2 and JNKMAPkinases via activation of protein kinase C in human renal tubular cells. Diabetologia 48, 187-97.
35. Tsimaratos, M., Roger, F., Chabardes, D., Mordasini, D., Hasler, U., Doucet, A., Martin, P. Y. and Feraille, E. (2003). C-peptide stimulates Na+,K+-ATPase activity via PKC alpha in rat medullary thick ascending limb. Diabetologia 46, 124-31.
36. Ohtomo, Y., Bergman, T., Johansson, B. L., Jornvall, H. and Wahren, J. (1998). Differential effects of proinsulin C-peptide fragments on Na+, K+-ATPase activity of renal tubule segments. Diabetologia 41, 287-91.
37. Grunberger, G., Qiang, X., Li, Z., Mathews, S. T., Sbrissa, D., Shisheva, A. and Sima, A. A. (2001). Molecular basis for the insulinomimetic effects of C-peptide. Diabetologia 44, 1247-57.
38. Al-Rasheed, N. M., Meakin, F., Royal, E. L., Lewington, A. J., Brown, J., Willars, G. B. and Brunskill, N. J. (2004). Potent activation of multiple signalling pathways by C-peptide in opossum kidney proximal tubular cells. Diabetologia 47, 987-97.
39. Kitamura, T., Kimura, K., Jung, B. D., Makondo, K., Sakane, N., Yoshida, T. and Saito, M. (2002). Proinsulin C-peptide activates cAMP response element-binding proteins through the p38 mitogen-activated protein kinase pathway in mouse lung capillary endothelial cells. Biochem. J. 366, 737-44.
40. Kitamura, T., Kimura, K., Makondo, K., Furuya, D. T., Suzuki, M., Yoshida, T. and Saito, M. (2003). Proinsulin C-peptide increases nitric oxide production by enhancing mitogen-activated protein-kinase-dependent transcription of endothelial nitric oxide synthase in aortic endothelial cells of Wistar rats. Diabetologia 46, 1698-705.
41. Kitamura, T., Kimura, K., Jung, B. D., Makondo, K., Okamoto, S., Canas, X., Sakane, N., Yoshida, T. and Saito, M. (2001). Proinsulin C-peptide rapidly stimulates mitogen-activated protein kinases in Swiss 3T3 fibroblasts: requirement of protein kinase C, phosphoinositide 3-kinase and pertussis toxin-sensitive G-protein. Biochem. J. 355, 123-9.
42. Scalia, R., Coyle, K. M., Levine, B. J., Booth, G. and Lefer, A. M. (2000). C-peptide inhibits leukocyte-endothelium interaction in the microcirculation during acute endothelial dysfunction. Faseb J. 14, 2357-64.
43. Shafqat, J., Juntti-Berggren, L., Zhong, Z., Ekberg, K., Kohler, M., Berggren, P. O., Johansson, J., Wahren, J. and Jornvall, H. (2002). Proinsulin C-peptide and its analogues induce intracellular Ca2+ increases in human renal tubular cells. Cell. Mol. Life Sci. 59, 1185-9.
44. Ekberg, K., Brismar, T., Johansson, B. L., Lindstrom, P., Juntti-Berggren, L., Norrby, A., Berne, C., Arnqvist, H. J., Bolinder, J. and Wahren, J. (2007). C-Peptide replacement therapy and sensory nerve function in type 1 diabetic neuropathy. Diabetes Care 30, 71-6.
45. Ido, Y., Vindigni, A., Chang, K., Stramm, L., Chance, R., Heath, W. F., DiMarchi, R. D., Di Cera, E. and Williamson, J. R. (1997). Prevention of vascular and neural dysfunction in diabetic rats by C-peptide. Science 277, 563-6.
46. Shafqat, J., Melles, E., Sigmundsson, K., Johansson, B. L., Ekberg, K., Alvelius, G., Henriksson, M., Johansson, J., Wahren, J. and Jornvall, H. (2006). Proinsulin C-peptide elicits disaggregation of insulin resulting in enhanced physiological insulin effects. Cell. Mol. Life Sci. 63, 1805-11.
47. Marx, N. and Walcher, D. (2008). C-Peptide and atherogenesis: C-Peptide as a mediator of lesion development in patients with type 2 diabetes mellitus? Exp. Diabetes Res. 2008, 385108.
48. Libby, P. (2002). Inflammation in atherosclerosis. Nature 420, 868-74.
49. Nishita, M., Aizawa, H. and Mizuno, K. (2002). Stromal cell-derived factor 1alpha activates LIM kinase 1 and induces cofilin phosphorylation for T-cell chemotaxis. Mol. Cell. Biol. 22, 774-83.
50. Ono, S. (2003). Regulation of actin filament dynamics by actin depolymerizing factor/cofilin and actin-interacting protein 1: new blades for twisted filaments. Biochemistry 42, 13363-70.
51. Pollard, T. D. and Borisy, G. G. (2003). Cellular motility driven by assembly and disassembly of actin filaments. Cell 112, 453-65.
52. Carlier, M. F., Laurent, V., Santolini, J., Melki, R., Didry, D., Xia, G. X., Hong, Y., Chua, N. H. and Pantaloni, D. (1997). Actin depolymerizing factor (ADF/cofilin) enhances the rate of filament turnover: implication in actin-based motility. J. Cell Biol. 136, 1307-22.
53. McGough, A., Pope, B., Chiu, W. and Weeds, A. (1997). Cofilin changes the twist of F-actin: implications for actin filament dynamics and cellular function. J. Cell Biol. 138, 771-81.
54. Alblas, J., Ulfman, L., Hordijk, P. and Koenderman, L. (2001). Activation of Rhoa and ROCK are essential for detachment of migrating leukocytes. Mol. Biol. Cell 12, 2137-45.
55. Lindahl, E., Nyman, U., Melles, E., Sigmundsson, K., Stahlberg, M., Wahren, J., Obrink, B., Shafqat, J., Joseph, B. and Jornvall, H. (2007). Cellular internalization of proinsulin C-peptide. Cell. Mol. Life Sci. 64, 479-86.
56. Cherla, R. P. and Ganju, R. K. (2001). Stromal cell-derived factor 1 alpha-induced chemotaxis in T cells is mediated by nitric oxide signaling pathways. J. Immunol. 166, 3067-74.
57. Smit, M. J., Verdijk, P., van der Raaij-Helmer, E. M., Navis, M., Hensbergen, P. J., Leurs, R. and Tensen, C. P. (2003). CXCR3-mediated chemotaxis of human T cells is regulated by a Gi- and phospholipase C-dependent pathway and not via activation of MEK/p44/p42 MAPK nor Akt/PI-3 kinase. Blood 102, 1959-65.
58. Grunberger, G., Weston, W. M., Patwardan, R. and Rappaport, E. B. (1999). Rosiglitazone once or twice daily improves glycemic control in patients with type II diabetes (T2D). Diabetes 49, 0439.
59. Cotter, M. A., Ekberg, K., Wahren, J. and Cameron, N. E. (2003). Effects of proinsulin C-peptide in experimental diabetic neuropathy: vascular actions and modulation by nitric oxide synthase inhibition. Diabetes 52, 1812-7.